THE GENE THERAPY
Gene therapy, an emergent pillar in the biotechnological treatment paradigm, aims to rectify or mitigate disorders at their molecular genesis. This technique involves the introduction, alteration, or replacement of DNA within specific cells, aiming to restore health or instigate therapeutic changes, either by counteracting defective genes or by providing new functionality to transfected cells.
OUR SPECIALIZED FOCUS: GENE ADDITION THERAPY
THE GENE, with its rigorous scientific grounding, has anchored its primary therapeutic modality in gene addition. Unlike gene editing which corrects mutations in situ, or gene replacement that swaps out faulty genes, gene addition introduces exogenous genes into the cellular machinery. These are carefully selected to bestow cells with functionalities that counteract genetic deficiencies or malfunctions. Drawing from comprehensive genomic databases and pathophysiological mapping, we are choosing genes that strategically augment pathways pivotal for health optimization, longevity and combating chronic disease.
UNPARALLELED RESEARCH INSIGHTS
What sets THE GENE apart is our vantage point in the scientific matrix. Through strategic affiliations and an unwavering commitment to rigorous scholarship, we gain access to not only published but also emergent, unreleased data from the global research community. This advantage translates into a prescient awareness of novel approaches not yet published. This proactive approach ensures we are not only responsive but often preemptive in identifying and harnessing new genes for therapy.
THE CIRCULAR DNA VECTOR
Our current preference for the backbone-reduced circular DNA vector isn't arbitrary. Rooted in molecular biotechnology, this vector contains NO parental bacterial remnants, ensuring a reduction in potential immunogenic responses. Furthermore, its configuration facilitates persistent expression of therapeutic genes without genomic integration, ensuring both efficacy and biocompatibility.
Learn more about our circular DNA vector system here.
THE GENE HORIZON
The trajectory of THE GENE is clear: to synergize cutting-edge genetic engineering with therapeutic innovation. As we advance, our gene therapy portfolio will expand, integrating a broader spectrum of genes and vectors, each scientifically and clinically vetted for best therapeutic effect.